About Fujirebio India Private Limited
Data last updated:
Fujirebio India Private Limited was a foreign private limited company based in New Delhi, Delhi, India, operated as a subsidiary of Fujirebio Holding, Inc.. The company has been dissolved under section 59(8) as per MCA records and no longer exists as a legal entity. Any dealings with a dissolved entity carry legal and financial risk. It operated in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 16 March 2017.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2017FTC314589. Its GSTIN is 07AADCF0415C1ZD (Delhi). The company held 3 GST registrations, all of them active.
The company had an authorised share capital of ₹42.45 Cr and a paid-up capital of ₹42.45 Cr. It was led by directors including Takeshi Fujita (Managing Director) and Goki Ishikawa.
Its last annual general meeting (AGM) was held on 18 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at First Floor The Great Eastern Centre 70 Nehru Place Behind Ifci Tower, New Delhi, Delhi, India – 110019.
As per the financials filed for FY 2020, the company reported a revenue of ₹3.15 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net loss of ₹18.38 Cr and EBITDA of -₹15.05 Cr (EBITDA margin -478.2%).
The company had about 21 employees on its provident fund (EPFO) records before it was dissolved.
The company was associated with 1 brand: Fujirebio. Court records list 1 case involving the company, including 1 filed by the company. The company has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in September 2019. Its 6 peer companies in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 1 larger and 5 smaller; the largest is Nugen Laboratories Private Limited with revenue of ₹3.15 Cr.
The last known website on record is fujirebio.com.
Company details
Contact details
Fujirebio India Private Limited's registered office is in New Delhi, Delhi. Its website is fujirebio.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressFirst Floor The Great Eastern Centre 70 Nehru Place Behind Ifci Tower, New Delhi, Delhi, India – 110019
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Fujirebio India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Fujirebio India operates one associated brand: Fujirebio. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| In vitro diagnostics solutions are developed, manufactured, and marketed. | fujirebio.com |
Business activity
The main business activity of Fujirebio India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Fujirebio India Private Limited, buy the company report.
Financials of Fujirebio India Private Limited
FY 2020 filings availableFujirebio India Private Limited reported revenue of ₹3.15 Cr (down 3% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue fell 3% in the latest year. EBITDA fell 92% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ₹3.15 Cr | |||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹15.05 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹18.38 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -478.2% | |||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Fujirebio India Private Limited, buy the company report.
Board of directors of Fujirebio India Private Limited
Fujirebio India has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Goki Ishikawa | Director | 16 Mar 2017 | 9 Years 7 Months | As last reported |
| Mitalee Kaushal Also directs: Takemoto Yohki India Private Limited, Topre India Private Limited, Kyosan India Private Limited and 1 more | Director | 16 Mar 2017 | 9 Years 7 Months | As last reported |
| Takeshi Fujita | Managing Director | 07 Jul 2018 | 8 Years 3 Months | As last reported |
Peer comparison
Fujirebio India Private Limited is compared with the 6 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nugen Laboratories Private Limited | ₹3.15 Cr (FY 2024) | -8.0% | Ahmedabad, Gujarat, India | |||
| Fujirebio India Private Limitedthis company | ₹3.15 Cr (FY 2020) | -₹18.38 Cr | -3.0% | 21 | New Delhi, Delhi, India | |
| Stackwell Industries Private Limited | ₹3.12 Cr (FY 2025) | -3.0% | Pune, Maharashtra, India | |||
| Javmed Healthcare Private Limited | ₹3.11 Cr (FY 2025) | 37.0% | Greater Noida, Uttar Pradesh, India | |||
| Analytical Automation (India) Private Limited | ₹3.11 Cr (FY 2025) | 14.0% | Navi Mumbai, Maharashtra, India | |||
| Acn Medicare Private Limited | ₹3.09 Cr (FY 2025) | 48.0% | Delhi, India | |||
| Grant Instruments India Private Limited | ₹3.09 Cr (FY 2025) | 8.0% | Delhi, India |
To see the full peer comparison of Fujirebio India Private Limited, buy the company report.
Auditor
Fujirebio India Private Limited is audited by Price Waterhouse Chartered Accountants LLP for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Price Waterhouse Chartered Accountants LLP | FY 2019 | 012754N/N500016 |
Shareholding
The shareholding of Fujirebio India Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Fujirebio India Private Limited, buy the company report.
Deals & funding
Fujirebio India Private Limited has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in September 2019.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2019 | Rights issue | ₹15.98 Cr | Investors: Fujirebio Holdings Inc |
| Dec 2017 | Rights issue | ₹18.98 Cr | Investors: Fujirebio Holdings Inc |
| Jul 2017 | Secondary share transfer | Undisclosed | Buyer: Fujirebio Holdings Inc Seller: Fujirebio Inc |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Fujirebio India Private Limited has 1 court case on record: 1 filed by Fujirebio India. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, New Delhi Bench Court-II | Insolvency matter | Filed by the company | Disposed |
To see the full case history of Fujirebio India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fujirebio India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Fujirebio India Private Limited has a workforce of 21 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
GST
Fujirebio India has 3 GST registrations: 3 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCF0415C1ZD | Delhi | Active | 11 Sep 2018 |
| 06AADCF0415C1ZF | Haryana | Active | 01 Jul 2017 |
| 27AADCF0415C1ZB | Maharashtra | Active | 25 May 2018 |
To see the full GST registrations and return filing status of Fujirebio India Private Limited, buy the company report.
Recent activity
Fujirebio India Private Limited has 6 board changes on record since 2017: 3 appointments and 3 cessations. The latest: Nobuhiro Yamamoto ceased to be Managing Director on 09 Jul 2020.
News
Frequently asked questions
Fujirebio India has been "Dissolved Under Section 59(8)" as per MCA records. The company has ceased to exist as a legal entity. Any contracts or dealings with a dissolved entity may be legally unenforceable.
Fujirebio India was a foreign private limited company based in New Delhi, Delhi, India. The company worked in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 16 March 2017 and is registered under CIN U51909DL2017FTC314589. The company is recorded as dissolved under section 59(8) in MCA records and no longer exists as a legal entity.
Fujirebio India was incorporated on 16 March 2017. It is registered with the Registrar of Companies, Delhi.
Fujirebio India had 3 directors:
- Takeshi Fujita - Managing Director
- Goki Ishikawa - Director
- Mitalee Kaushal - Director
The CIN (Corporate Identification Number) of Fujirebio India is U51909DL2017FTC314589. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Fujirebio India is at First Floor The Great Eastern Centre 70 Nehru Place Behind Ifci Tower, New Delhi, Delhi, India – 110019.
Fujirebio India can be reached through the website fujirebio.com. Its registered office is in New Delhi, Delhi, India.
The latest financial statements of Fujirebio India on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 18 December 2020. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Fujirebio India is 07AADCF0415C1ZD, registered in Delhi. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 06AADCF0415C1ZF (Haryana), 27AADCF0415C1ZB (Maharashtra).
Fujirebio India operated in the healthcare industry, in the medical equipment retail and distribution segment.
Fujirebio India has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in September 2019.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
